Deephealth Expands Its AI-Powered Cancer Diagnostic and Screening Portfolio with the Acquisition of Kheiron
DeepHealth has acquired Kheiron Medical Technologies Limited, a UK-based AI cancer diagnostic company focused on developing deep learning solutions to support radiologists improve breast cancer detection. Kheiron’s Mia® (Mammography Intelligent Assessment) suite of AI solutions for breast cancer screening is a strong fit with DeepHealth’s portfolio roadmap aimed at large-scale diagnostic and screening programs leveraging AI-powered health informatics solutions.
